Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cytochrome P450 2B6 Inhibitors [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
CANNABIDIOL 18,243 1,563 8.6% 5,149 104 21.6 yrs 45.2%
CRIZOTINIB 9,948 3,173 31.9% 2,520 279 58.5 yrs 55.2%
CENOBAMATE 5,643 125 2.2% 1,012 94 38.2 yrs 56.4%
PEXIDARTINIB 970 17 1.8% 91 4 44.9 yrs 63.4%
VILOXAZINE 853 9 1.1% 59 24 21.6 yrs 47.2%
LEVOKETOCONAZOLE 309 8 2.6% 99 0 54.8 yrs 86.3%
TRICLABENDAZOLE 42 0 N/A 4 2 43.3 yrs 44.7%

Head-to-Head Comparisons

CANNABIDIOL vs CRIZOTINIB CANNABIDIOL vs CENOBAMATE CANNABIDIOL vs PEXIDARTINIB CANNABIDIOL vs VILOXAZINE CRIZOTINIB vs CENOBAMATE CRIZOTINIB vs PEXIDARTINIB CRIZOTINIB vs VILOXAZINE CENOBAMATE vs PEXIDARTINIB CENOBAMATE vs VILOXAZINE PEXIDARTINIB vs VILOXAZINE
← Back to Cytochrome P450 2B6 Inhibitors [MoA] Class side effects →